Brett Trauthen Email

CSO . Ivantis

Current Roles

Employees:
77
Revenue:
$19.3M
About
Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery. But each of these has its limitations. Glaucoma remains the leading cause of blindness worldwide, in need of better treatment alternatives. It is our goal to develop new and effective solutions for ophthalmology specialists and the 70 million people worldwide who are affected by this debilitating and sight-stealing disease.
Ivantis Address
201 Technology
null, null
Ivantis Email

Past Companies

Ivantis, IncCSO
Devax, IncCSO
Conor MedsystemsVice President, Clinical Affairs

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.